🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
4.500
-0.260 (-5.46%)
At close: Nov 19, 2026, 4:00 PM EST
4.240
-0.260 (-5.78%)
After-hours: Nov 19, 2026, 7:59 PM EST

Cue Biopharma Revenue

Cue Biopharma had revenue of $132.00K in the quarter ending September 30, 2026, a decrease of -93.86%. This brings the company's total for the last twelve months to $35.64M, up 401.93% year-over-year. In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth. That makes Cue Biopharma the 30,323rd largest company in the world by revenue and 4,000th in the United States.

Revenue (ttm)
$35.64M
Revenue Growth
+401.93%
P/S Ratio
0.91
Revenue / Employee
$1,228,897
Employees
29
Market Cap
32.69M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.47M18.18M195.75%
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Celularity18.67M
Immutep13.79M
Metagenomi Therapeutics7.09M
Lipocine3.74M
BeyondSpring1.88M
IGC Pharma1.11M
Cocrystal Pharma435.00K
CervoMed8.73K
Revenue Rankings